Literature DB >> 21129446

A greater role for the norepinephrine transporter than the serotonin transporter in murine nociception.

F S Hall1, J M Schwarzbaum, M T G Perona, J S Templin, M G Caron, K-P Lesch, D L Murphy, G R Uhl.   

Abstract

Norepinephrine and serotonin involvement in nociceptive functions is supported by observations of analgesic effects of norepinephrine transporter (NET) and serotonin transporter (SERT) inhibitors such as amitriptyline. However, the relative contribution of NET and SERT to baseline nociception, as well as amitriptyline analgesia, is unclear. Amitriptyline and morphine analgesia in wild-type (WT) mice and littermates with gene knockout (KO) of SERT, NET or both transporters was conducted using the hotplate and tail-flick tests. Hypoalgesia was observed in NET KO mice, and to a lesser extent in SERT KO mice. The magnitude of this hypoalgesia in NET KO mice was so profound that it limited the assessment of drug-induced analgesia. Nonetheless, the necessary exclusion of these subjects because of profound baseline hypoalgesia strongly supports the role of norepinephrine and NET in basal nociceptive behavior while indicating a much smaller role for serotonin and SERT. To further clarify the role of NET and SERT in basal nociceptive sensitivity further experiments were conducted in SERT KO and NET KO mice across a range of temperatures. NET KO mice were again found to have pronounced thermal hypoalgesia compared to WT mice in both the hotplate and tail-flick tests, while only limited effects were observed in SERT KO mice. Furthermore, in the acetic acid writhing test of visceral nociception pronounced hypoalgesia was again found in NET KO mice, but no change in SERT KO mice. As some of these effects may have resulted from developmental consequences of NET KO, the effects of the selective NET blocker nisoxetine and the selective SERT blocker fluoxetine were also examined in WT mice: only nisoxetine produced analgesia in these mice. Collectively these data suggest that NET has a far greater role in determining baseline analgesia, and perhaps other analgesic effects, than SERT in mice. Published by Elsevier Ltd.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21129446      PMCID: PMC3030457          DOI: 10.1016/j.neuroscience.2010.11.057

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  95 in total

1.  Antinociception induced by electrical stimulation of spinally projecting noradrenergic neurons in the A7 catecholamine cell group of the rat.

Authors:  David C Yeomans; Frank M Clark; Judith A Paice; Herbert K Proudfit
Journal:  Pain       Date:  1992-03       Impact factor: 6.961

2.  Chronic administration of amitriptyline and caffeine in a rat model of neuropathic pain: multiple interactions.

Authors:  M J Esser; T Chase; G V Allen; J Sawynok
Journal:  Eur J Pharmacol       Date:  2001-11-02       Impact factor: 4.432

3.  The interaction between gabapentin and amitriptyline in the rat formalin test after systemic administration.

Authors:  Caroline E Heughan; Jana Sawynok
Journal:  Anesth Analg       Date:  2002-04       Impact factor: 5.108

4.  Differential contribution of descending serotonergic and noradrenergic systems to central Tyr-D-Ala2-Gly-NMePhe4-Gly-ol5 (DAMGO) and morphine-induced antinociception in mice.

Authors:  K S Arts; B B Holmes; J M Fujimoto
Journal:  J Pharmacol Exp Ther       Date:  1991-03       Impact factor: 4.030

5.  Synergistic antinociceptive effect of amitriptyline and morphine in the rat orofacial formalin test.

Authors:  Philippe Luccarini; Laurent Perrier; Céline Dégoulange; Anne-Marie Gaydier; Radhouane Dallel
Journal:  Anesthesiology       Date:  2004-03       Impact factor: 7.892

6.  Roles of alpha1- and alpha2-adrenoceptors in the nucleus raphe magnus in opioid analgesia and opioid abstinence-induced hyperalgesia.

Authors:  B Bie; H L Fields; J T Williams; Z Z Pan
Journal:  J Neurosci       Date:  2003-08-27       Impact factor: 6.167

7.  Topical amitriptyline in healthy volunteers.

Authors:  Peter Gerner; Grace Kao; Venkatesh Srinivasa; Sanjeet Narang; Ging Kuo Wang
Journal:  Reg Anesth Pain Med       Date:  2003 Jul-Aug       Impact factor: 6.288

8.  Antinociceptive effects of spinal cholinesterase inhibition and isobolographic analysis of the interaction with mu and alpha 2 receptor systems.

Authors:  M Naguib; T L Yaksh
Journal:  Anesthesiology       Date:  1994-06       Impact factor: 7.892

9.  Transgenic superoxide dismutase mice differ in opioid-induced analgesia.

Authors:  G I Elmer; J L Evans; B Ladenheim; C J Epstein; J L Cadet
Journal:  Eur J Pharmacol       Date:  1995-09-05       Impact factor: 4.432

10.  Intrathecal amitriptyline acts as an N-methyl-D-aspartate receptor antagonist in the presence of inflammatory hyperalgesia in rats.

Authors:  J C Eisenach; G F Gebhart
Journal:  Anesthesiology       Date:  1995-11       Impact factor: 7.892

View more
  13 in total

1.  Effects of repeated treatment with monoamine-transporter-inhibitor antidepressants on pain-related depression of intracranial self-stimulation in rats.

Authors:  L P Legakis; L Karim-Nejad; S S Negus
Journal:  Psychopharmacology (Berl)       Date:  2020-05-08       Impact factor: 4.530

2.  5-HT3 receptor signaling in serotonin transporter-knockout rats: a female sex-specific animal model of visceral hypersensitivity.

Authors:  Nadine El-Ayache; James J Galligan
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2018-10-25       Impact factor: 4.052

Review 3.  The mu-opioid receptor agonist/noradrenaline reuptake inhibition (MOR-NRI) concept in analgesia: the case of tapentadol.

Authors:  Thomas M Tzschentke; Thomas Christoph; Babette Y Kögel
Journal:  CNS Drugs       Date:  2014-04       Impact factor: 5.749

4.  Effects of monoamine reuptake inhibitors in assays of acute pain-stimulated and pain-depressed behavior in rats.

Authors:  Marisa B Rosenberg; F Ivy Carroll; S Stevens Negus
Journal:  J Pain       Date:  2013-01-16       Impact factor: 5.820

5.  Neuropathic and inflammatory pain are modulated by tuberoinfundibular peptide of 39 residues.

Authors:  Eugene L Dimitrov; Jonathan Kuo; Kenji Kohno; Ted B Usdin
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-22       Impact factor: 11.205

6.  Straub tail reaction in mice treated with σ(1) receptor antagonist in combination with methamphetamine.

Authors:  Junichi Kitanaka; Nobue Kitanaka; F Scott Hall; George R Uhl; Koh-Ichi Tanaka; Nobuyoshi Nishiyama; Motohiko Takemura
Journal:  Brain Res       Date:  2012-09-08       Impact factor: 3.252

7.  Norepinephrine transporter heterozygous knockout mice exhibit altered transport and behavior.

Authors:  H M Fentress; R Klar; J J Krueger; T Sabb; S N Redmon; N M Wallace; J K Shirey-Rice; M K Hahn
Journal:  Genes Brain Behav       Date:  2013-10-09       Impact factor: 3.449

8.  Preclinical to clinical translation of CNS transporter occupancy of TD-9855, a novel norepinephrine and serotonin reuptake inhibitor.

Authors:  Jacqueline A M Smith; D L Bourdet; D L Patil; O T Daniels; Y-S Ding; J-D Gallezot; S Henry; K H S Kim; S Kshirsagar; W J Martin; G P Obedencio; E Stangeland; P R Tsuruda; W Williams; R E Carson; S T Patil
Journal:  Int J Neuropsychopharmacol       Date:  2014-12-13       Impact factor: 5.176

9.  Altered reward circuitry in the norepinephrine transporter knockout mouse.

Authors:  Joseph J Gallagher; Xiaowei Zhang; F Scott Hall; George R Uhl; Elaine L Bearer; Russell E Jacobs
Journal:  PLoS One       Date:  2013-03-04       Impact factor: 3.240

10.  Impaired noradrenaline homeostasis in rats with painful diabetic neuropathy as a target of duloxetine analgesia.

Authors:  Jun Kinoshita; Yukari Takahashi; Ayako M Watabe; Kazunori Utsunomiya; Fusao Kato
Journal:  Mol Pain       Date:  2013-11-27       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.